Renaissance Capital logo

Vitae Pharmaceuticals Priced, Nasdaq: VTAE

Developing small molecule drugs for type 2 diabetes and Alzheimer's.

Industry: Health Care

First Day Return: -4.9%

Developing small molecule drugs for type 2 diabetes and Alzheimer's.
IPO Data
IPO Date 09/24/2014
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $55
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Fort Washington, PA, United States
Founded 2001
Employees at IPO 52
Website www.vitaepharma.com

Vitae Pharmaceuticals (VTAE) Performance

Created with Highcharts 10.3.2Chart context menuVTAE vs. IPO Index (IPOUSA)20152016201720182019202020212022202320242025-100%0%+ 100%+ 200%+ 300%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index